An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably

Autores
Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; Halliday, Daniel; Heath, Joseph; Herzog, Lisa; Leland, R. J.; Lemango, Ephrem T.; Luna, Florencia; McCoy, Matthew S.; Norheim, Ole F.; Ottersen, Trygve; Schaefer, G. Owen; Tan, Kok-Chor; Wellman, Christopher Heath; Wolff, Jonathan; Richardson, Henry S.
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution.
Fil: Emanuel, Ezekiel J.. University of Pennsylvania; Estados Unidos
Fil: Persad, Govind. University of Denver.; Estados Unidos
Fil: Kern, Adam. University of Princeton; Estados Unidos
Fil: Buchanan, Allen. University of Arizona; Estados Unidos
Fil: Fabre, Cécile. All Souls College; Reino Unido
Fil: Halliday, Daniel. University of Melbourne; Australia
Fil: Heath, Joseph. University of Toronto; Canadá
Fil: Herzog, Lisa. University of Groningen; Países Bajos
Fil: Leland, R. J.. University of Manitoba; Canadá
Fil: Lemango, Ephrem T.. No especifíca;
Fil: Luna, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Facultad Latinoamericana de Ciencias Sociales; Argentina
Fil: McCoy, Matthew S.. University of Pennsylvania; Estados Unidos
Fil: Norheim, Ole F.. University of Bergen; Noruega
Fil: Ottersen, Trygve. Norwegian Institute Of Public Health; Noruega
Fil: Schaefer, G. Owen. Yong Loo Lin School Of Medicine; Singapur
Fil: Tan, Kok-Chor. University of Pennsylvania; Estados Unidos
Fil: Wellman, Christopher Heath. Washington University in St. Louis; Estados Unidos
Fil: Wolff, Jonathan. University of Oxford; Reino Unido
Fil: Richardson, Henry S.. Kennedy Institute Of Ethics; Estados Unidos
Materia
COVID-19
VACCINE
DISTRIBUTION
EQUITY
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/145501

id CONICETDig_2213545b81d70392b55de49bbca3488f
oai_identifier_str oai:ri.conicet.gov.ar:11336/145501
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitablyEmanuel, Ezekiel J.Persad, GovindKern, AdamBuchanan, AllenFabre, CécileHalliday, DanielHeath, JosephHerzog, LisaLeland, R. J.Lemango, Ephrem T.Luna, FlorenciaMcCoy, Matthew S.Norheim, Ole F.Ottersen, TrygveSchaefer, G. OwenTan, Kok-ChorWellman, Christopher HeathWolff, JonathanRichardson, Henry S.COVID-19VACCINEDISTRIBUTIONEQUITYhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution.Fil: Emanuel, Ezekiel J.. University of Pennsylvania; Estados UnidosFil: Persad, Govind. University of Denver.; Estados UnidosFil: Kern, Adam. University of Princeton; Estados UnidosFil: Buchanan, Allen. University of Arizona; Estados UnidosFil: Fabre, Cécile. All Souls College; Reino UnidoFil: Halliday, Daniel. University of Melbourne; AustraliaFil: Heath, Joseph. University of Toronto; CanadáFil: Herzog, Lisa. University of Groningen; Países BajosFil: Leland, R. J.. University of Manitoba; CanadáFil: Lemango, Ephrem T.. No especifíca;Fil: Luna, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Facultad Latinoamericana de Ciencias Sociales; ArgentinaFil: McCoy, Matthew S.. University of Pennsylvania; Estados UnidosFil: Norheim, Ole F.. University of Bergen; NoruegaFil: Ottersen, Trygve. Norwegian Institute Of Public Health; NoruegaFil: Schaefer, G. Owen. Yong Loo Lin School Of Medicine; SingapurFil: Tan, Kok-Chor. University of Pennsylvania; Estados UnidosFil: Wellman, Christopher Heath. Washington University in St. Louis; Estados UnidosFil: Wolff, Jonathan. University of Oxford; Reino UnidoFil: Richardson, Henry S.. Kennedy Institute Of Ethics; Estados UnidosAmerican Association for the Advancement of Science2020-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/145501Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; et al.; An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably; American Association for the Advancement of Science; Science; 369; 6509; 9-2020; 1309-13120036-8075CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://science.sciencemag.org/content/369/6509/1309info:eu-repo/semantics/altIdentifier/doi/10.1126/SCIENCE.ABE2803info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:34:09Zoai:ri.conicet.gov.ar:11336/145501instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:34:09.979CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
title An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
spellingShingle An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
Emanuel, Ezekiel J.
COVID-19
VACCINE
DISTRIBUTION
EQUITY
title_short An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
title_full An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
title_fullStr An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
title_full_unstemmed An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
title_sort An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
dc.creator.none.fl_str_mv Emanuel, Ezekiel J.
Persad, Govind
Kern, Adam
Buchanan, Allen
Fabre, Cécile
Halliday, Daniel
Heath, Joseph
Herzog, Lisa
Leland, R. J.
Lemango, Ephrem T.
Luna, Florencia
McCoy, Matthew S.
Norheim, Ole F.
Ottersen, Trygve
Schaefer, G. Owen
Tan, Kok-Chor
Wellman, Christopher Heath
Wolff, Jonathan
Richardson, Henry S.
author Emanuel, Ezekiel J.
author_facet Emanuel, Ezekiel J.
Persad, Govind
Kern, Adam
Buchanan, Allen
Fabre, Cécile
Halliday, Daniel
Heath, Joseph
Herzog, Lisa
Leland, R. J.
Lemango, Ephrem T.
Luna, Florencia
McCoy, Matthew S.
Norheim, Ole F.
Ottersen, Trygve
Schaefer, G. Owen
Tan, Kok-Chor
Wellman, Christopher Heath
Wolff, Jonathan
Richardson, Henry S.
author_role author
author2 Persad, Govind
Kern, Adam
Buchanan, Allen
Fabre, Cécile
Halliday, Daniel
Heath, Joseph
Herzog, Lisa
Leland, R. J.
Lemango, Ephrem T.
Luna, Florencia
McCoy, Matthew S.
Norheim, Ole F.
Ottersen, Trygve
Schaefer, G. Owen
Tan, Kok-Chor
Wellman, Christopher Heath
Wolff, Jonathan
Richardson, Henry S.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COVID-19
VACCINE
DISTRIBUTION
EQUITY
topic COVID-19
VACCINE
DISTRIBUTION
EQUITY
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution.
Fil: Emanuel, Ezekiel J.. University of Pennsylvania; Estados Unidos
Fil: Persad, Govind. University of Denver.; Estados Unidos
Fil: Kern, Adam. University of Princeton; Estados Unidos
Fil: Buchanan, Allen. University of Arizona; Estados Unidos
Fil: Fabre, Cécile. All Souls College; Reino Unido
Fil: Halliday, Daniel. University of Melbourne; Australia
Fil: Heath, Joseph. University of Toronto; Canadá
Fil: Herzog, Lisa. University of Groningen; Países Bajos
Fil: Leland, R. J.. University of Manitoba; Canadá
Fil: Lemango, Ephrem T.. No especifíca;
Fil: Luna, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Facultad Latinoamericana de Ciencias Sociales; Argentina
Fil: McCoy, Matthew S.. University of Pennsylvania; Estados Unidos
Fil: Norheim, Ole F.. University of Bergen; Noruega
Fil: Ottersen, Trygve. Norwegian Institute Of Public Health; Noruega
Fil: Schaefer, G. Owen. Yong Loo Lin School Of Medicine; Singapur
Fil: Tan, Kok-Chor. University of Pennsylvania; Estados Unidos
Fil: Wellman, Christopher Heath. Washington University in St. Louis; Estados Unidos
Fil: Wolff, Jonathan. University of Oxford; Reino Unido
Fil: Richardson, Henry S.. Kennedy Institute Of Ethics; Estados Unidos
description Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution.
publishDate 2020
dc.date.none.fl_str_mv 2020-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/145501
Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; et al.; An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably; American Association for the Advancement of Science; Science; 369; 6509; 9-2020; 1309-1312
0036-8075
CONICET Digital
CONICET
url http://hdl.handle.net/11336/145501
identifier_str_mv Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; et al.; An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably; American Association for the Advancement of Science; Science; 369; 6509; 9-2020; 1309-1312
0036-8075
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://science.sciencemag.org/content/369/6509/1309
info:eu-repo/semantics/altIdentifier/doi/10.1126/SCIENCE.ABE2803
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Association for the Advancement of Science
publisher.none.fl_str_mv American Association for the Advancement of Science
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613055902646272
score 13.070432